Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maguire

Showing results (501-510 of 566) with videos related to

Pageof 57
Sort By:
British Journal of Clinical Pharmacology|June 24, 2022
Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney functionDuuamene Nyimanu, Fiona A Chapman, Peter J Gallacher, et al.
Hypertension (Dallas, Tex. : 1979)|February 26, 2015
Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonistAimee L Brame, Janet J Maguire, Peiran Yang, et al.
Pharmacological Reviews|March 10, 2016
EndothelinAnthony P Davenport, Kelly A Hyndman, Neeraj Dhaun, et al.
Journal of the American Heart Association|October 16, 2016
Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat VasculatureAmanda J Kennedy, Peiran Yang, Cai Read, et al.
Scientific Reports|December 22, 2021
Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sitesThomas L Williams, Gregory Strachan, Robyn G C Macrae, et al.
Pharmacological Reviews|March 27, 2026
International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applicationsAnthony P Davenport, Thomas L Williams, Duuamene Nyimanu, et al.
Plos Neglected Tropical Diseases|August 16, 2021
The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platformBrittany J Maguire, Prabin Dahal, Sumayyah Rashan, et al.
Journal of Pediatric Orthopedics|September 16, 2024
Medial Patellofemoral Ligament Reconstruction Improves Patella AltaDaniel Z Yang, Kevin Orellana, Nathan V Houlihan, et al.
Frontiers in Pharmacology|March 15, 2021
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis <i>In Vitro</i> and Induces Vasodilatation Without Desensitisation <i>In Vivo</i>Cai Read, Duuamene Nyimanu, Peiran Yang, et al.
Journal of Environmental Management|April 28, 2022
A new direction for tackling phosphorus inefficiency in the UK food systemS A Rothwell, K J Forber, C J Dawson, et al.
Pageof 57

Showing results (501-510 of 566) with videos related to

Sort By:
Pageof 57
British Journal of Clinical Pharmacology|June 24, 2022
Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney functionDuuamene Nyimanu, Fiona A Chapman, Peter J Gallacher, et al.
Hypertension (Dallas, Tex. : 1979)|February 26, 2015
Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonistAimee L Brame, Janet J Maguire, Peiran Yang, et al.
Pharmacological Reviews|March 10, 2016
EndothelinAnthony P Davenport, Kelly A Hyndman, Neeraj Dhaun, et al.
Journal of the American Heart Association|October 16, 2016
Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat VasculatureAmanda J Kennedy, Peiran Yang, Cai Read, et al.
Scientific Reports|December 22, 2021
Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sitesThomas L Williams, Gregory Strachan, Robyn G C Macrae, et al.
Pharmacological Reviews|March 27, 2026
International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applicationsAnthony P Davenport, Thomas L Williams, Duuamene Nyimanu, et al.
Plos Neglected Tropical Diseases|August 16, 2021
The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platformBrittany J Maguire, Prabin Dahal, Sumayyah Rashan, et al.
Journal of Pediatric Orthopedics|September 16, 2024
Medial Patellofemoral Ligament Reconstruction Improves Patella AltaDaniel Z Yang, Kevin Orellana, Nathan V Houlihan, et al.
Frontiers in Pharmacology|March 15, 2021
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis <i>In Vitro</i> and Induces Vasodilatation Without Desensitisation <i>In Vivo</i>Cai Read, Duuamene Nyimanu, Peiran Yang, et al.
Journal of Environmental Management|April 28, 2022
A new direction for tackling phosphorus inefficiency in the UK food systemS A Rothwell, K J Forber, C J Dawson, et al.
Pageof 57